SAB Biotherapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KSAB Biotherapeutics, Inc.SABSW6d

   SAB Biotherapeutics gets FDA Fast Track for T1D treatment

   • FDA grants Fast Track to SAB-142 for Stage 3 T1D
   • SAB-142 is a disease-modifying immunotherapy
   • Phase 2b trial SAFEGUARD to complete enrollment in Q4 2026
2. ROUTINE4SAB Biotherapeutics, Inc.SABSWSep 18

   Alexandra Kropotova, insider filing for SABSW

   Alexandra Kropotova, reporting

3. ROUTINE424B3SAB Biotherapeutics, Inc.SABSWAug 21

   Securities offering

4. ROUTINESCHEDULE 13G/ASAB Biotherapeutics, Inc.SABSWAug 14

   4 13G filings

   Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

   Show all 4

   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14
   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14
   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14
   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14

   PERCEPTIVE ADVISORS LLC, filed by

5. ROUTINESCHEDULE 13G/ASAB Biotherapeutics, Inc.SABSWAug 14

   Ownership stake disclosure by Woodline Partners LP (amended)

   Woodline Partners LP, filed by

6. ROUTINESCHEDULE 13G/ASAB Biotherapeutics, Inc.SABSWAug 14

   Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)

   BALYASNY ASSET MANAGEMENT L.P., filed by

7. ROUTINESCHEDULE 13GSAB Biotherapeutics, Inc.SABSWAug 12

   Ownership stake disclosure by Adage Capital Management, L.P.

   Adage Capital Management, L.P., filed by

8. NOTABLESCHEDULE 13D/ASAB Biotherapeutics, Inc.SABSWAug 10

   Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

   RA CAPITAL MANAGEMENT, L.P., filed by

9. NOTABLE10-QSAB Biotherapeutics, Inc.SABSWAug 6

   Quarterly report

10. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWJul 7

    Current report

11. ROUTINE4SAB Biotherapeutics, Inc.SABSWJun 26

    Alexandra Kropotova, insider filing for SABSW

    Alexandra Kropotova, reporting

12. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWJun 18

    Current report

13. ROUTINESCHEDULE 13G/ASAB Biotherapeutics, Inc.SABSWMay 15

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

    PERCEPTIVE ADVISORS LLC, filed by

14. ROUTINESCHEDULE 13GSAB Biotherapeutics, Inc.SABSWMay 15

    Ownership stake disclosure by Caligan Partners LP

    Caligan Partners LP, filed by

15. ROUTINESCHEDULE 13GSAB Biotherapeutics, Inc.SABSWMay 15

    Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P.

    BALYASNY ASSET MANAGEMENT L.P., filed by

16. NOTABLE10-QSAB Biotherapeutics, Inc.SABSWMay 12

    Quarterly report

17. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWMay 4

    Current report

18. ROUTINESCHEDULE 13GSAB Biotherapeutics, Inc.SABSWMay 1

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

    MILLENNIUM MANAGEMENT LLC, filed by

19. ROUTINEDEF 14ASAB Biotherapeutics, Inc.SABSWApr 30

    Proxy statement

20. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWApr 22

    Current report

21. ROUTINES-8SAB Biotherapeutics, Inc.SABSWMar 31

    Employee stock plan registration

22. ROUTINE4SAB Biotherapeutics, Inc.SABSWMar 25

    Alexandra Kropotova, insider filing for SABSW

    Alexandra Kropotova, reporting

23. NOTABLESCHEDULE 13D/ASAB Biotherapeutics, Inc.SABSWMar 23

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

24. ROUTINE424B5SAB Biotherapeutics, Inc.SABSWMar 17

    Securities offering

25. NOTABLESCHEDULE 13D/ASAB Biotherapeutics, Inc.SABSWMar 11

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

26. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWMar 10

    Current report

27. NOTABLE10-KSAB Biotherapeutics, Inc.SABSWMar 9

    Annual report

28. ROUTINESCHEDULE 13G/ASAB Biotherapeutics, Inc.SABSWFeb 17

    Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)

    BIOTECHNOLOGY VALUE FUND L P, filed by

29. ROUTINESCHEDULE 13G/ASAB Biotherapeutics, Inc.SABSWFeb 17

    Ownership stake disclosure by RTW INVESTMENTS, LP (amended)

    RTW INVESTMENTS, LP, filed by

30. ROUTINE4SAB Biotherapeutics, Inc.SABSWFeb 5

    5 insider filings

    Eddie Joe Sullivan, insider filing for SABSW

    Show all 5

    • 4Insider filing for SABSWFeb 5
    • 4Insider filing for SABSWFeb 5
    • 4Insider filing for SABSWFeb 5
    • 4Insider filing for SABSWFeb 5
    • 4Insider filing for SABSWFeb 5

    Eddie Joe Sullivan, reporting

31. ROUTINESCHEDULE 13GSAB Biotherapeutics, Inc.SABSWJan 22

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC

    PERCEPTIVE ADVISORS LLC, filed by

32. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWJan 12

    Current report

33. ROUTINEEFFECTSAB Biotherapeutics, Inc.SABSWJan 8

    Registration declared effective

34. ROUTINE4SAB Biotherapeutics, Inc.SABSWJan 7

    4 insider filings

    Rita Jain, insider filing for SABSW

    Show all 4

    • 4Insider filing for SABSWJan 7
    • 4Insider filing for SABSWJan 7
    • 3New insider at SABSWJan 7
    • 3New insider at SABSWJan 7

    Rita Jain, reporting

35. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWJan 7

    Current report

36. ROUTINES-3SAB Biotherapeutics, Inc.SABSWDec 30, 2025

    Securities offering

37. ROUTINE8-KSAB Biotherapeutics, Inc.SABSWDec 29, 2025

    Current report

38. ROUTINE4SAB Biotherapeutics, Inc.SABSWDec 18, 2025

    3 insider filings

    Jay S Skyler, insider filing for SABSW

    Show all 3

    • 4Insider filing for SABSWDec 18, 2025
    • 4Insider filing for SABSWDec 18, 2025
    • 4Insider filing for SABSWDec 18, 2025

    Jay S Skyler, reporting

Older filings on EDGAR